All stock lists
Ryde Group Ltd. (New York Stock Exchange Arca:RYDE)
SG · Delayed Price · Currency is USD
Technology · Software - Application
0.89+0.15 (+20.55%)
Market cap
$134M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 8, 2024
Website
Insider Score
––Not scored
RYDE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Fair
From RYDE’s reported statements · Q2 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $22.1M
- Net income
- -$33.5M
- Net margin
- -151.5%
Leverage20 / 20
Little or no net debt.
- Total debt
- $20K
- Cash
- $2.8M
- Debt / equity
- 0.00
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $54.4M
- Current liabilities
- $5.7M
- Current ratio
- 9.60
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$26.8M
- Free cash flow
- -$27.1M
- FCF margin
- -122.7%
Dilution & runway0 / 20
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 142.3M
- Share growth (1y)
- 569.2%
- Cash runway
- 1 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
RYDE Income Statement
| Fiscal Period | Q2 2026 | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Dec 31, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 |
| Revenue | 6.74 M | 6.76 M | 5.75 M | 2.87 M | 4.57 M | 2.29 M |
| Revenue Growth (YoY) | 47.25 % | 195.50 % | 31.35 % | 31.35 % | 33.16 % | -56.29 % |
| Cost of Revenue | 20.41 M | 19.31 M | 10.63 M | 2.06 M | 9.77 M | 1.90 M |
| Gross Profit | -13.68 M | -12.55 M | -4.89 M | 809.00 K | -5.19 M | 390.50 K |
| SG&A Expense | 0.00 | 0.00 | 0.00 | 1.55 M | 0.00 | 1.00 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 1.55 M | 0.00 | 1.00 M |
| Operating Income | -13.68 M | -12.55 M | -4.89 M | -737.00 K | -5.19 M | -612.50 K |
| Pretax Income | -13.42 M | -12.64 M | -4.84 M | -2.42 M | -5.13 M | -2.57 M |
| Tax Provision | 0.00 | 0.00 | -32.00 K | 16.00 K | 0.00 | 0.00 |
| Net Income | -13.41 M | -12.88 M | -4.81 M | -2.40 M | -5.12 M | -2.56 M |
| EPS (Basic) | -0.09 | -0.29 | -0.18 | -0.09 | -0.24 | -0.10 |
| EPS (Diluted) | -0.09 | -0.29 | -0.18 | -0.09 | -0.24 | -0.10 |
| Shares Outstanding | 142.27 M | 44.80 M | 27.39 M | 27.39 M | 21.26 M | 25.94 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.